COVID-19 and neurodegeneration: what can we learn from the past?
作者信息
Gatto E M, Fernandez Boccazzi J
机构信息
Departamento de Neurología, Sanatorio de la Trinidad Mitre, Ciudad Autonoma de Buenos Aires, Argentina.
Instituto de Neurociencias Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina.
出版信息
Eur J Neurol. 2020 Sep;27(9):e45. doi: 10.1111/ene.14311. Epub 2020 Jun 8.
Abstract
摘要
相似文献
1
COVID-19 and neurodegeneration: what can we learn from the past?
Eur J Neurol. 2020 Sep;27(9):e45. doi: 10.1111/ene.14311. Epub 2020 Jun 8.
2
Concerns Raised by Publication of Antonini et al., "Outcome of Parkinson Disease Patients Affected by Covid-19".
Mov Disord. 2020 Aug;35(8):1297. doi: 10.1002/mds.28180.
3
Editorial: Neuropalliative care for movement disorders in the time of COVID-19.
Parkinsonism Relat Disord. 2020 Nov;80:201-202. doi: 10.1016/j.parkreldis.2020.10.045. Epub 2020 Nov 19.
4
COVID-19 in Parkinson's disease: Report on prevalence and outcome.
Parkinsonism Relat Disord. 2020 Nov;80:7-9. doi: 10.1016/j.parkreldis.2020.09.008. Epub 2020 Sep 6.
5
Medical education in movement disorders during the COVID-19 pandemic.
Parkinsonism Relat Disord. 2020 Aug;77:11-12. doi: 10.1016/j.parkreldis.2020.06.013. Epub 2020 Jun 15.
6
Behind the Mask: Recognizing Facial Features of Parkinson's Disease During the COVID-19 Pandemic.
Mov Disord. 2021 Jun;36(6):1285-1286. doi: 10.1002/mds.28619. Epub 2021 Apr 28.
7
A Post-COVID-19 Parkinsonism in the Future?
Mov Disord. 2020 Jul;35(7):1094. doi: 10.1002/mds.28117. Epub 2020 May 21.
8
May Parkinson's disease be a protective factor against CNS involvement by SARS-CoV2?
Parkinsonism Relat Disord. 2020 Aug;77:20. doi: 10.1016/j.parkreldis.2020.06.012. Epub 2020 Jun 18.
9
Impact of home confinement during COVID-19 pandemic on Parkinson's disease.
Parkinsonism Relat Disord. 2020 Nov;80:32-34. doi: 10.1016/j.parkreldis.2020.09.003. Epub 2020 Sep 6.
10
In reply to: Helmich and Bloem (2020) "The Impact of the COVID-19 Pandemic on Parkinson's Disease: Hidden Sorrows and Emerging Opportunities".
J Parkinsons Dis. 2020;10(3):1267-1268. doi: 10.3233/JPD-202169.
引用本文的文献
1
SARS-CoV-2 impairs the disassembly of stress granules and promotes ALS-associated amyloid aggregation.
Protein Cell. 2022 Aug;13(8):602-614. doi: 10.1007/s13238-022-00905-7. Epub 2022 Apr 6.
2
Can COVID-19 accelerate neurodegeneration?
Clin Case Rep. 2021 Jul 9;9(7):e04433. doi: 10.1002/ccr3.4433. eCollection 2021 Jul.
本文引用的文献
1
Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicentre polymerase chain reaction based case-control study.
Eur J Neurol. 2020 Sep;27(9):1738-1741. doi: 10.1111/ene.14273. Epub 2020 May 16.
2
Neurologic complications of coronavirus infections.
Neurology. 2020 May 12;94(19):809-810. doi: 10.1212/WNL.0000000000009455. Epub 2020 Mar 30.
3
Viremic attack explains the dual-hit theory of Parkinson's disease.
Med Hypotheses. 2017 Apr;101:33-36. doi: 10.1016/j.mehy.2017.02.007. Epub 2017 Feb 16.
4
A historical analysis of the relationship between encephalitis lethargica and postencephalitic parkinsonism: a complex rather than a direct relationship.
Mov Disord. 2010 Jul 15;25(9):1116-23. doi: 10.1002/mds.22908.
5
Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease.
Mov Disord. 1992;7(2):153-8. doi: 10.1002/mds.870070210.
Zotero 插件